Abstract | PURPOSE: METHODS: A total of 24 postmortem porcine eyes with debrided corneas were subdivided into three treatment groups: Controls, the isoosmolar group with isoosmolar 0.1% riboflavin-20% dextran solution and the hypoosmolar group with dextran-free, 0.1% riboflavin solution. The samples were irradiated with UVA light of 365 nm wavelength and an irradiance of 3 mW/cm² for 30 min (dose 5.4 J/cm²). For the biomechanical measurements, 400-µm-deep anterior corneal flaps were created using a lamellar rotating microkeratome. Uniaxial stress-strain measurements were performed. RESULTS: In the isoosmolar treatment group, stress and Young's modulus at 8% strain were significantly increased by 67.97%, respectively, 62.62% versus the controls. In the hypoosmolar treatment group, stress and Young's modulus at 8% strain were significantly increased by 81.21%, respectively, 51.40% versus the controls. There was no significant difference between the iso- and hypoosmolar groups in biomechanical efficacy. On histology, there was no edema in the anterior 200 µm of the corneas after stromal swelling by the hypoosmolar riboflavin solution. CONCLUSION:
Corneal cross-linking using isoosmolar or hypoosmolar riboflavin solution induces a comparable biomechanical effect. This is explained by the localization of the maximum cross-linking effect in the anterior 200 µm of the cornea which are not affected by the swelling effect of hypoosmolar riboflavin solution.
|
Authors | Gregor Wollensak, Eberhard Spörl |
Journal | European journal of ophthalmology
(Eur J Ophthalmol)
Vol. 29
Issue 5
Pg. 474-481
(Sep 2019)
ISSN: 1724-6016 [Electronic] United States |
PMID | 30255714
(Publication Type: Journal Article)
|
Chemical References |
- Cross-Linking Reagents
- Photosensitizing Agents
- Collagen
- Riboflavin
|
Topics |
- Animals
- Biomechanical Phenomena
- Collagen
(metabolism)
- Cornea
(drug effects, physiology)
- Corneal Stroma
(metabolism)
- Cross-Linking Reagents
- Elastic Modulus
(physiology)
- Osmolar Concentration
- Photochemotherapy
(methods)
- Photosensitizing Agents
(therapeutic use)
- Riboflavin
(therapeutic use)
- Swine
- Ultraviolet Rays
|